miR-31-5p Regulates 14-3-3 ɛ to Inhibit Prostate Cancer 22RV1 Cell Survival and Proliferation via PI3K/AKT/Bcl-2 Signaling Pathway
Author:
Publisher
Informa UK Limited
Subject
Oncology
Reference56 articles.
1. Analysis of Cancer Incidence in Zhejiang Cancer Registry in China during 2000 to 2009
2. LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9-5p/QKI-5axis
3. National cancer institute. Prostate cancer treatment. 2018:https://www.cancer.gov/types/prostate/hp/prostate-treatment-pdq. Accessed July 9, 2020.
4. Immune checkpoint inhibitors in mCRPC - rationales, challenges and perspectives
5. The development of androgen-independent prostate cancer
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. 14–3-3ε: a protein with complex physiology function but promising therapeutic potential in cancer;Cell Communication and Signaling;2024-01-26
2. PI3K/Akt signaling in urological cancers: Tumorigenesis function, therapeutic potential, and therapy response regulation;European Journal of Pharmacology;2023-09
3. Prostate cancer and microRNAs: New insights into apoptosis;Pathology - Research and Practice;2023-05
4. Development and validation of a urinary microRNA biomarker panel as a tool for early detection of prostate cancer in a Chinese population;Biomarkers;2023-04-26
5. LncRNA SNHG16 Knockdown Promotes Diabetic Foot Ulcer Wound Healing via Sponging MiR-31-5p;The Tohoku Journal of Experimental Medicine;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3